Late-stage development, FDA marketing authorization, procurement, and stockpile of antibiotics for the treatment of drug-resistant secondary bacterial infections and/or the treatment or PEP of infections caused by biothreat pathogens. ....
Solicitation Type : AWARD
Posted Date :Apr 09, 2026
Inactive Date : Apr 21, 2026